Antimicrobial quinolones, their compositions and uses

1. A compound having the following formula:

wherein:

(a) X is

(b) R1 is selected from the group consisting of C 3 to about C 5 cycloalkyl, C 1 to about C 2 alkanyl, C 2 to about C 3 linear alkenyl, C 3 to about C 4 branched alkanyl or alkenyl, all such alkyl or cycloalkyl moieties being unsubstituted or substituted with from 1 to about 3 fluoro; and phenyl, unsubstituted or substituted with from 1 to about 3 fluoro, or with one hydroxy in the 4-position;

(c) R3 is hydrogen or hydroxy;

(d) R5 is selected from the group consisting of hydrogen, hydroxy, amino, halo, C 1 to about C 2 alkanyl, C 2 alkenyl, and methoxy, all such alkyl and methoxy moieties being unsubstituted or substituted with from 1 to about 3 fluoro;

(e) R8 is selected from the group consisting of fluoro, chloro and bromo;

(f) R7 is amino which is attached to a ring carbon of X which is not adjacent to the ring nitrogen, the amino being unsubstituted or substituted with one or two C 1 to about C 3 alkanyl; and

(g) each R9 is independently selected from the group consisting of hydrogen, C 1 to about C 4 alkanyl, C 2 to about C 6 alkenyl or alkynyl, and a C 3 to about C 6 fused or spirocycle alkyl ring; or one R9 may optionally be selected from the group consisting of hydroxy, C 1 to about C 4 alkoxy, aryl and heteroaryl, all other R9 being hydrogen; all alkyl and aryl portions of R9 moieties being unsubstituted or substituted with one hydroxy or with from 1 to about 3 fluoro;

or an optical isomer, diastereomer or enantiomer thereof; a pharmaceutically-acceptable salt, hydrate, or biohydrolyzable ester, amid, or imide thereof.

2. The compound of claim 1 wherein R3 is hydroxy.

3. The compound of claim 2 wherein each R9 is independently selected from the group consisting of hydrogen, C 1 to about C 4 alkanyl, C 2 to about C 6 alkenyl Or alkynyl, and a C 3 to about C 6 fused or spirocycle alkyl ring; all such alkyl moieties being unsubstituted or substituted with from 1 to about 3 fluoro.

4. The compound of claim 3 wherein:

(a) R1 is selected from the group consisting of C 3 to C 5 cycloalkanyl, methyl, ethyl, ethenyl, isopropyl, isopropenyl, isobutyl, isobutenyl, t-butyl, all such alkyl or cycloalkanyl moieties being unsubstituted or substituted with from 1 to 3 fluoro; and phenyl, unsubstituted or substituted with from 1 to 3 fluoro, or with one hydroxy in the 4-position;

(b) R5 is selected from the group consisting of hydrogen, hydroxy, amino, fluoro, chloro, bromo, and methyl, the methyl being unsubstituted or substituted with from 1 to 3 fluoro;

(c) R7 is attached to a ring carbon of X which is not adjacent to the ring nitrogen; and

(d) no mom than two ring carbons of X have non-hydrogen R9's attached thereto.

5. The compound of claim 4 wherein R8 is chloro.

6. The compound of claim 4 wherein

(a) R1 is selected from the group consisting of cyclopropyl, ethyl, phenyl substituted with 1 to 3 fluoro, and 4-hydroxyphenyl;

(b) R5 is selected from the group consisting of hydrogen, hydroxy, amino, and methyl;

(c) R7 is amino in the 3-position of the piperidinyl ring; and

(d) all R9 are hydrogen, or one non-hydrogen R9 is in the 4-position or 5-position of the piperidinyl ring.

7. The compound of claim 6 wherein

(a) R1 is cyclopropyl;

(b) R5 is hydrogen, and

(c) all R9 are hydrogen, or one non-hydrogen R9 is selected form the group consisting or methyl, ethyl, dimethyl, spirocyclopropyl, methoxy, 2-thienyl and 2-furyl.

8. The compound of claim 7 wherein R8 is chloro.

9. The compound of claim 4 wherein:

(a) R1 is selected from the group consisting of cyclopropyl, ethyl, phenyl substituted with 1 to 3 fluoro, and 4-hydroxyphenyl; and

(b) R5 is selected from the group consisting of hydrogen, hydroxy, chloro, bromo, amino, and methyl, the methyl being unsubstituted or substituted with from 1 to 3 fluoro.

10. The compound of claim 9 wherein:

(a) R1 is cyclopropyl or ethyl, unsubstituted or substituted with from 1 to about 3 fluoro;

(b) R5 is selected from the group consisting of hydrogen, hydroxy, amino, and methyl; and

(c) all R9 are hydrogen or only one ring carbon of X has a non-hydrogen R9 attached thereto, such non-hydrogen R9 being selected from the group consisting of methyl, ethyl, dimethyl and spirocyclopropyl.

11. A compound selected from the group consisting of:

7-[3S-aminopiperidinyl]-1-cyclopropyl-1,4-dihydro-8-chloro-6-hydroxy-4-oxo-3-quinolinecarboxylic acid;

7-[3S-methylaminopiperidinyl]-1-cyclopropyl-1,4-dihydro-8-chloro-6-hydroxy-4-oxo-3-quinolinecarboxylic acid;

7-[3S-amino-4R-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-chloro-6-hydroxy-4-oxo-3-quinolinecarboxylic acid;

7-[3S-amino-5S-ethyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-chloro-6-hydroxy-4-oxo-3-quinolinecarboxylic acid;

7-[3S-amino-5R-methyl-piperdinyl]-1-cyclopropyl-1,4-dihydro-8-chloro-6-hydroxy-4-oxo-3-quinolinecarboxylic acid;

7-[3S-amino-5R-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-chloro-6-hydroxy-4-oxo-3-quinolinecarboxylic acid;

7-[3S-amino-4R-ethyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-chloro-6-hydroxy-4-oxo-3-quinolinecarboxylic acid;

7-[7-amino-5-amino-6-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-chloro-6-hydroxy-4-oxo-3-quinolinecarboxylic acid;

7-[3S-amino-6-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-chloro-6-hydroxy-4-oxo-3-quinolinecarboxylic acid;

7-[7-amino-5-azaspiro[2.5]-octanyl]1-cyclopropyl-1,4-dihydro-8-chloro-6-hydroxy 4-oxo-3-quinolinecarboxylic acid;

7-[4-amino-6-azaspiro[2.5]-octanyl]-1-cyclopropyl-1,4-dihydro-8-chloro-6-hydroxy-4-oxo-3-quinolinecarboxylic acid;

or a pharmaceutically-acceptable salt thereof.

12. The compound of claim 1 wherein R9 is selected from the group consisting of C1 to about C4 alkanyl.

13. The compound of claim 12 wherein R9 is selected from the group consisting of methyl and ethyl.

14. The compound of claim 13 wherein R9 is methyl.

15. The compound of claim 13 wherein R9 is ethyl.

16. A pharmaceutical composition comprising:

(a) a safe and effective amount of a compound of claim 1 ; and

(b) a pharmaceutically-acceptable excipient.

17. A method for preventing or treating microbial infection comprising administering to a host in need of such a treatment a safe and antimicrobially effective amount of a compound of claim 1 .

18. A pharmaceutical composition comprising:

(a) a safe and effective amount of a compound of claim 11 ; and

(b) a pharmaceutically-acceptable excipient.

19. A method for preventing or treating microbial infection comprising administering to a host in need of such a treatment a safe and antimicrobially effective amount of a compound of claim 11 .